Halozyme Therapeutics Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 10 trades in Halozyme Therapeutics Inc (NASDAQ: HALO) since 2017, across 4 members, worth an estimated $846.50K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 4 buys against 6 sells, a modestly sell-led skew, with Democratic members responsible for 100% of the trades and Republican members 0%. One notable disclosed move was a purchase by Gilbert Cisneros on March 9, 2026, up 60.4% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. Halozyme Therapeutics Inc's current Quantellect Tide Score is 60 out of 100 (High Tide), Top 31% of universe (3876); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Halozyme Therapeutics Inc (HALO) stock overview and the complete trade table below.
Data updated
Price & congressional trade timeline
Party breakdown
Halozyme Therapeutics congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | Owner | |
|---|---|---|---|---|---|---|---|---|
 Gilbert Cisneros House | Apr 7, 2026 | Mar 9, 2026 | 29 days | BUY |  $1,001 - $15,000 | +60.43% | Self |
Halozyme Therapeutics (HALO) congressional trading FAQ
Can members of Congress legally trade Halozyme Therapeutics (HALO) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Halozyme Therapeutics (HALO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.
Are congressional Halozyme Therapeutics (HALO) trades public?
Yes. Every congressional trade in Halozyme Therapeutics (HALO) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Halozyme Therapeutics (HALO)?
Members of Congress have disclosed 10 trades in Halozyme Therapeutics (HALO) worth $846.50K across 4 members, according to public STOCK Act filings.
Which members of Congress have traded Halozyme Therapeutics (HALO)?
Recent and active filers of Halozyme Therapeutics (HALO) disclosures include Gilbert Cisneros. The full member-by-member trade list is on this page.
Do Democrats or Republicans trade Halozyme Therapeutics (HALO) more?
Across disclosed Halozyme Therapeutics (HALO) trades, 100% were by Democrats and 0% by Republicans, led by Democrats (100%).
What is the most recent congressional Halozyme Therapeutics (HALO) trade?
The most recent disclosed Halozyme Therapeutics (HALO) trade was a purchase by Gilbert Cisneros, filed Apr 6, 2026.
What is Halozyme Therapeutics (HALO)'s Tide Score?
Halozyme Therapeutics (HALO) has a Quantellect Tide Score of 60 (High Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.
Browse all stocks Congress tradesCongressional trading overviewHalozyme Therapeutics (HALO) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.